Friday, May 02, 2014 1:31:42 PM
MSN
5-2-14
http://healthyliving.msn.com/health-wellness/sleep/us-approves-first-of-its-kind-implant-for-sleep-apnea
The Inspire Upper Airway Stimulation therapy, which has been given the green light by the US Food and Drug Administration, is designed for patients unable to benefit from available therapies.
(WASHINGTON) - US regulators have approved a first-of-its-kind implant that can help ward off moderate to severe sleep apnea, a chronic disorder which affects up to 18 million Americans.
Sleep apnea is a condition in which the breathing passage collapses or becomes blocked during sleep -- complications can include heart disease and increased risks of accidents and death.
The Inspire Upper Airway Stimulation therapy, which has been given the green light by the US Food and Drug Administration, is designed for patients unable to benefit from available therapies.
The device contains a small neurostimulation generator that is surgically implanted in the chest, along with a lead that stimulates a nerve that runs from the ear to the jaw, and another sensing lead that goes to the chest.
Once implanted, the device can be activated before bed time with a remote control.
The product is expected to be available to consumers later this year, but a spokeswoman for the Minnesota-based Inspire Medical Systems said a price has not been decided.
Research published earlier this year in the New England Journal of Medicine found that it led to a 68 percent reduction in apnea events and significant improvements in daytime function.
"This therapy represents a major advance in sleep apnea treatment for some patients," said Meir Kryger, professor at the Yale School of Medicine.
"There is a significant need for safe, effective and well-tolerated new treatments in the sleep medicine field."
<<<
Recent RSPI News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:05:55 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:15:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 12:52:24 PM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM